Enacts provisions relating to insurance coverage of alternatives to opioid drugs

Based solely on the provided context, a detailed summary of SB 158's specific provisions cannot be generated. The bill title and abstract only state it relates to "insurance coverage of alternatives to opioid drugs" without describing concrete mechanisms, affected groups, or policy changes. The recent actions (committee referral, hearing, and "Do Pass" vote) indicate legislative progress but do not reveal the bill's actual requirements or scope. Without additional details about what the bill mandates regarding coverage, which insurers or plans it affects, or specific alternatives to opioids it addresses, a factual summary meeting the requested criteria cannot be provided. The context lacks sufficient information to describe key mechanisms or policy changes.